Prospective Clinical Validation of a Novel Multitarget FIT in CRC Screening

UnknownOBSERVATIONAL
Enrollment

14,712

Participants

Timeline

Start Date

March 25, 2022

Primary Completion Date

May 31, 2023

Study Completion Date

May 31, 2023

Conditions
CRCAdvanced Neoplasia
Interventions
DIAGNOSTIC_TEST

Comparison of two tests (FIT and mtFIT) in the same bowel movement

Invitees for the Dutch National CRC screening program will be randomly selected by the Screening Organization and invited to participate in this study, where next to the current FIT, participants will also perform the mtFIT in one bowel movement. Both tests will be analysed and if one of the two test results is positive, the individual will be referred for colonoscopy.

Trial Locations (1)

Unknown

Netherlands Cancer Institute, Amsterdam

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)

OTHER

collaborator

Erasmus Medical Center

OTHER

lead

The Netherlands Cancer Institute

OTHER

NCT05314309 - Prospective Clinical Validation of a Novel Multitarget FIT in CRC Screening | Biotech Hunter | Biotech Hunter